Review paper:
Kim PS; Djazayeri S; Zeineldin R. Novel nanotechnology
approaches to diagnosis and therapy of ovarian cancer.
Gynecologic Oncology. 2011, 120:393-403.
Dr. Paul Kim PharmD Class of 2012
|
Dr. Shabdis Djazayeri PharmD Class of 2012
|
Amal Abdulghani Graduate Student
|
Mohamed Sayed, Hui En Huang, Mary Rhorer, Oyebola Oladeinde, Reema Zeineldin. Role of Rac1 in ovarian cancer.
Annual Meeting for the American Association of Pharmaceutical Scientists-North East Regional Discussion Group
(AAPS-NERDG). Rocky Hill, CT. April 19, 2013.
Amal Abdulghani, Reema Zeineldin. Developing a biosensor for reactive oxygen species. Gordon Conference on Bioanalytical Sensors. Salve Regina University,
Newport, RI. June 22-27, 2014.
Hui En Huang, Reema Zeineldin. Rac1 inhibitor improves ovarian cancer sensitivity to cisplatin. Submitted to 2013 American Society of Health-Systems Pharmacists
(ASHP) Midyear Clinical Meeting. Orlando, FL. December 8-12, 2013.
Amal Abdulghani, Reema Zeineldin. Releasing content of lipid drug delivery vehicles by immune-related molecules. Second Cancer Nanotechnology Gordon Research
Conference. Mount Snow Resort, West Dover, VT. July 14-19, 2013.
Reema Zeineldin, Ph.D.